Comparison

Erlotinib European Partner

Item no. TMO-T0373-200mg
Manufacturer TargetMol
CASRN 183321-74-6
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 500 mg 50 mg
Category
Type Molecules
Specific against other
Purity 0,98
Citations 1. Moyer JD, et al. Y Res. 1997, 57(21), 4838-4848.
Smiles N(C=1C2=C(C=C(OCCOC)C(OCCOC)=C2)N=CN1)C3=CC(C#C)=CC=C3
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias OSI-744,R1415,NSC 718781,CP358774
Shipping Condition Cool pack
Available
Manufacturer - Targets
EGFR|||Autophagy
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
393.44
Description
Erlotinib (NSC-718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.
Pathways
JAK/STAT signaling|||Autophagy|||Angiogenesis|||Tyrosine Kinase/Adaptors
Bioactivity
Erlotinib (NSC 718781; OSI-744; R1415) is an EGFR inhibitor (IC50 of 2 nM). It is >1000-fold more sensitive for EGFR than human v-Abl or c-Src.
Receptor
EGFR

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close